Should we reconsider the routine use of placebo controls in clinical research?

Trials

Volumn 13, Issue , 2012, Pages

  Avins, Andrew L ^a,b,c   Cherkin, Daniel C ^d   Sherman, Karen J ^d   Goldberg, Harley ^a   Pressman, Alice ^a  

^a DIVISION OF RESEARCH   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Blinding; Clinical trials; Masking; Placebo controls; Placebo effect; Placebos

Indexed keywords

PLACEBO;

ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROL GROUP; HUMAN; INTERNAL VALIDITY; METHODOLOGY; PLACEBO EFFECT; CONTROLLED CLINICAL TRIAL (TOPIC); ETHICS; PATIENT SELECTION;

CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT SELECTION; PLACEBO EFFECT; PLACEBOS; RESEARCH DESIGN;

EID: 84862225385     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-13-44     Document Type: Article

References (27)

1. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001, 344:1594-1602. 10.1056/NEJM200105243442106, 11372012.
2. Miller FG, Rosenstein DL. The nature and power of the placebo effect. J Clin Epidemiol 2006, 59:331-335. 10.1016/j.jclinepi.2005.12.001, 16549251.
3. Ernst E. Placebo: new insights into an old enigma. Drug Discov Today 2007, 12:413-418. 10.1016/j.drudis.2007.03.007, 17467578.
4. Greene PJ, Wayne PM, Kerr CE, Weiger WA, Jacobson E, Goldman P, Kaptchuk TJ. The powerful placebo: doubting the doubters. Adv Mind Body Med 2001, 17:298-307. discussion 312-318.
5. Oken BS. Placebo effects: clinical aspects and neurobiology. Brain 2008, 131:2812-2823. 10.1093/brain/awn116, 2725026, 18567924.
6. Colloca L, Benedetti F. Placebos and painkillers: is mind as real as matter?. Nat Rev Neurosci 2005, 6:545-552. 10.1038/nrn1705, 15995725.
7. Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995, 346:1231. 10.1016/S0140-6736(95)92938-X, 7475687.
8. Sherman R, Hickner J. Academic physicians use placebos in clinical practice and believe in the mind-body connection. J Gen Intern Med 2008, 23:7-10. 2150628,2150628, 18095037.
9. Tilburt JC, Emanuel EJ, Kaptchuk TJ, Curlin FA, Miller FG. Prescribing " placebo treatments" : results of national survey of US internists and rheumatologists. BMJ 2008, 337:a1938. 10.1136/bmj.a1938, 2572204, 18948346.
10. Bok S. The ethics of giving placebos. Sci Am 1974, 231:17-23. 10.1038/scientificamerican1174-17, 4432060.
11. Brody H. The lie that heals: the ethics of giving placebos. Ann Intern Med 1982, 97:112-118.
12. Hinks TS. Ends never justify means. BMJ 2007, 334:1072. 1877932, 17525411.
13. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One 2010, 5:e15591. 10.1371/journal.pone.0015591, 3008733, 21203519.
14. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967, 20:637-648. 10.1016/0021-9681(67)90041-0, 4860352.
15. Estrada CA, Young MJ. Patient preferences for novel therapy: an N-of-1 trial of garlic in the treatment for hypertension. J Gen Intern Med 1993, 8:619-621. 10.1007/BF02599719, 8289103.
16. Cook DJ. Randomized trials in single subjects: the N of 1 study. Psychopharmacol Bull 1996, 32:363-367.
17. Vickers AJ, de Craen AJ. Why use placebos in clinical trials? A narrative review of the methodological literature. J Clin Epidemiol 2000, 53:157-161. 10.1016/S0895-4356(99)00139-0, 10729687.
18. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev 2009, 1:CD001218. 3099267, 19160193.
19. Furlan AD, van Tulder M, Cherkin D, Tsukayama H, Lao L, Koes B, Berman B. Acupuncture and dry-needling for low back pain: an updated systematic review within the framework of the cochrane collaboration. Spine (Phila Pa 1976) 2005, 30:944-963.
20. Miller FG, Kallmes DF, Buchbinder R. Vertebroplasty and the placebo response. Radiology 2011, 259:621-625. 10.1148/radiol.11102412, 3099043, 21602500.
21. Omar MA, Wilson JP, Cox TS. Rhabdomyolysis and HMG-CoA reductase inhibitors. Ann Pharmacother 2001, 35:1096-1107.
22. Hlatky MA. Expanding the orbit of primary prevention-moving beyond JUPITER. N Engl J Med 2008, 359:2280-2282. 10.1056/NEJMe0808320, 18997195.
23. Hrobjartsson A, Kaptchuk TJ, Miller FG. Placebo effect studies are susceptible to response bias and to other types of biases. J Clin Epidemiol 2011, 64:1223-1229. 10.1016/j.jclinepi.2011.01.008, 21524568.
24. Furberg B, Furberg C. Why is blinding/masking so important?. Evaluating clinical research 2007, 10. Springer, New York.
25. Dieppe P. Osteoarthritis of the knee in primary care. BMJ 2008, 336:105-106. 10.1136/bmj.39412.592477.80, 2206305, 18056741.
26. Sokol DK. Can deceiving patients be morally acceptable?. BMJ 2007, 334:984-986. 10.1136/bmj.39184.419826.80, 1867874, 17494019.
27. Kupperman HS, Wetchler BB, Blatt MH. Contemporary therapy of the menopausal syndrome. J Am Med Assoc 1959, 171:1627-1637. 10.1001/jama.1959.03010300001001, 14412840.